In vitro manogepix susceptibility testing of South African Emergomyces africanus, Emergomyces pasteurianus, and Blastomyces emzantsi clinical isolates
- PMID: 37971237
- PMCID: PMC10720492
- DOI: 10.1128/aac.01104-23
In vitro manogepix susceptibility testing of South African Emergomyces africanus, Emergomyces pasteurianus, and Blastomyces emzantsi clinical isolates
Abstract
We performed in vitro antifungal susceptibility testing of manogepix against the yeast phase of 78 Emergomyces africanus, 2 Emergomyces pasteurianus, and 5 Blastomyces emzantsi isolates using a reference broth microdilution method following Clinical and Laboratory Standards Institute recommendations. All three pathogens had low minimum inhibitory concentrations ranging from <0.0005 to 0.008 mg/L. Manogepix should be investigated in animal models and potentially in future human clinical trials for endemic mycoses.
Keywords: APX001A; antifungal susceptibility testing; blastomycosis; emergomycosis; manogepix; thermally dimorphic fungi.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
In Vitro Antifungal Susceptibility of Yeast and Mold Phases of Isolates of Dimorphic Fungal Pathogen Emergomyces africanus (Formerly Emmonsia sp.) from HIV-Infected South African Patients.J Clin Microbiol. 2017 Jun;55(6):1812-1820. doi: 10.1128/JCM.02524-16. Epub 2017 Mar 29. J Clin Microbiol. 2017. PMID: 28356416 Free PMC article.
-
Human Blastomycosis in South Africa Caused by Blastomyces percursus and Blastomyces emzantsi sp. nov., 1967 to 2014.J Clin Microbiol. 2020 Feb 24;58(3):e01661-19. doi: 10.1128/JCM.01661-19. Print 2020 Feb 24. J Clin Microbiol. 2020. PMID: 31896663 Free PMC article.
-
Cross-reactivity of a Histoplasma capsulatum antigen enzyme immunoassay in urine specimens from persons with emergomycosis in South Africa.Med Mycol. 2021 Jul 6;59(7):672-682. doi: 10.1093/mmy/myaa100. Med Mycol. 2021. PMID: 33330930
-
Emergomycosis, an Emerging Systemic Mycosis in Immunocompromised Patients: Current Trends and Future Prospects.Front Med (Lausanne). 2021 Apr 23;8:670731. doi: 10.3389/fmed.2021.670731. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33968970 Free PMC article. Review.
-
Review: Emergomycosis.J Mycol Med. 2023 Mar;33(1):101313. doi: 10.1016/j.mycmed.2022.101313. Epub 2022 Jul 23. J Mycol Med. 2023. PMID: 36272380 Review.
References
-
- Kenyon C, Bonorchis K, Corcoran C, Meintjes G, Locketz M, Lehloenya R, Vismer HF, Naicker P, Prozesky H, van Wyk M, Bamford C, du Plooy M, Imrie G, Dlamini S, Borman AM, Colebunders R, Yansouni CP, Mendelson M, Govender NP. 2013. A dimorphic fungus causing disseminated infection in South Africa. N Engl J Med 369:1416–1424. doi: 10.1056/NEJMoa1215460 - DOI - PubMed
-
- Thompson GR, Le T, Chindamporn A, Kauffman CA, Alastruey-Izquierdo A, Ampel NM, Andes DR, Armstrong-James D, Ayanlowo O, Baddley JW, et al. 2021. Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of medical mycology in cooperation with the International society for human and animal mycology. Lancet Infect Dis 21:e364–e374. doi: 10.1016/S1473-3099(21)00191-2 - DOI - PMC - PubMed
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources